SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma’s arm recalling Mirtazapine tablets in US

03 Jan 2020 Evaluate

Aurobindo Pharma’s arm -- Aurobindo Pharma USA Inc is voluntarily recalling Mirtazapine tablets, used for the treatment of major depressive disorder, in the US market. The product is being recalled due to a label error on declared strength.

Mirtazapine tablets are indicated for the treatment of major depressive disorder and are packaged in 500 count bottle.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1406.45 15.30 (1.10%)
22-Apr-2026 12:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.20
Dr. Reddys Lab 1220.70
Cipla 1233.85
Zydus Lifesciences 931.20
Lupin 2307.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×